How does leuprolide affect the risk of venous thromboembolism during ovarian stimulation cycles, and what precautions are necessary to mitigate these risks?
Gaurav ChauhanContributor
How does leuprolide affect the risk of venous thromboembolism during stimulation cycles?
Share
Leuprolide used in ovarian stimulation can heighten the risk of venous thromboembolism (VTE). To reduce this risk, monitor coagulation parameters closely and encourage adequate hydration.